Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality

Background  Mortality in coronavirus disease of 2019 (COVID-19) is associated with increases in prothrombotic parameters, particularly D-dimer levels. Anticoagulation has been proposed as therapy to decrease mortality, often adjusted for illness severity. Objective  We wanted to investigate whether...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Thromb Haemost
Autors principals: Billett, Henny H., Reyes-Gil, Morayma, Szymanski, James, Ikemura, Kenji, Stahl, Lindsay R., Lo, Yungtai, Rahman, Shafia, Gonzalez-Lugo, Jesus D., Kushnir, Margarita, Barouqa, Mohammad, Golestaneh, Ladan, Bellin, Eran
Format: Artigo
Idioma:Inglês
Publicat: Georg Thieme Verlag KG 2020
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7869055/
https://ncbi.nlm.nih.gov/pubmed/33186991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0040-1720978
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars